Vaxart Inc.
09/19/2025 | Press release | Distributed by Public on 09/19/2025 04:04
Material Event (Form 8-K)
|
Item 8.01
|
Other Events.
|
Vaxart, Inc. (the "Company") previously disclosed in its current report on Form 8-K, filed with the Securities and Exchange Commission (the "SEC") on September 8, 2025, that the Company convened its special meeting of stockholders (the "Special Meeting") on September 5, 2025, but adjourned the Special Meeting to provide the Company's stockholders with additional time to vote on the proposal (the "Proposal") listed in the proxy statement, which the Company filed with the SEC on August 6, 2025, for the Special Meeting. The reconvened Special Meeting was scheduled for September 19, 2025.
On September 18, 2025, the Company determined to withdraw the Proposal from stockholder consideration and will not be reconvening the adjourned Special Meeting.
Vaxart Inc. published this content on September 19, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 19, 2025 at 10:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]